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INTRODUCTION
Juvenile nasopharyngeal angiofibroma (JNA) is an uncom-
mon tumor originating primarily in the nasopharynx with
extension to surrounding structures such as nasal cavity, sphe-
noid sinus, sella, pterygomaxillary fossa, infratemporal space,
inferior orbital fissure, and intracranial region (1). It repre-
sents 0.05% to 0.5% of all head and neck tumors (2, 3). Al-
though the tumor is histologically benign, local destructive
behaviors of the tumor may lead to serious consequences such
as fatal epistaxis and intracranial extension (1). Many modali-
ties have been tried for management of JNA. However, only
surgery and external beam radiation therapy were acknowl-
edged as effective treatment modalities for tumor control. Of
them, surgery has been the gold standard treatment for JNA
up to date (4). Nevertheless, determining optimal modality
for advanced lesions continues to be a controversial problem
because of complications associated with surgical resection
and potential delayed morbidity of radiation therapy (5). 
The authors report a successful management of recurred
orbital JNA patient with gamma knife surgery (GKS).
CASE REPORT
A 48-yr-old man was presented with right visual acuity
deterioration which had been found in regular medical check-
up. Eyesight test revealed 0.4 and 1.2 in right and left eye
respectively. There were no other abnormalities in neurolog-
ical examination including visual field and eye motion. Phys-
ical examination revealed mild exophthalmos when observed
closely. Brain magnetic resonance images (MRI) disclosed a
3 cm-sized intraorbital mass in the right orbit. He underwent
a right fronto-temporal craniotomy with opening of lateral
wall and roof of the orbit for direct access to the mass. The
mass was subtotally removed to preserve the visual function
(Fig. 1). Immediate postoperative visual acuity in right eye
was preserved to be 0.5. Histological diagnosis confirmed a
diagnosis of JNA in typical nature (Fig. 2). However, the
vision gradually became worse and finally failed four years
after the operation. Magnetic resonance images then showed
regrowth of the tumor occupying most of the right orbit (Fig.
3). As the complete resection of the tumor was a difficult task
due to adjacent vital structures, the patient was treated with
GKS. Tumor volume was measured 6.8 cm3 and a dose of 17
Gy was delivered to the 50% isodose line of tumor margin
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Recurrent Juvenile Nasopharyngeal Angiofibroma Treated with Gamma
Knife Surgery
Radiosurgery has been rarely applied for juvenile nasopharyngeal angiofibroma
(JNA) and cumulative reports are lacking. The authors report a case of successful
treatment of recurred JNA with gamma knife surgery (GKS). A 48-yr-old man was
presented with right visual acuity deterioration and brain magnetic resonance images
(MRI) disclosed a 3 cm-sized intraorbital mass in the right orbit. He underwent a
right fronto-temporal craniotomy and the mass was subtotally removed to preserve
visual function. Histological diagnosis confirmed JNA in typical nature. However,
the vision gradually worsened to fail four years after operation. MRI then showed
regrowth of the tumor occupying most of the right orbit. GKS was done for the re-
curred lesion. A dose of 17 Gy was delivered to the 50% isodose line of tumor mar-
gin. During the following four-year follow-up period, the mass disappeared almost
completely without any complications. Usually JNA can be exclusively diagnosed
by radiological study alone. So this report of successful treatment of JNA with GKS
may provide an important clue for the novel indication of GKS.
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(Fig. 4). Because the right vision of the patient was completely
lost at the time of GKS, care was taken only to optic chiasm
and contra-lateral optic nerve. The maximum radiation dose
to this part of optic pathway was 5.4 Gy. Plugs were used to
reduce radiation dose to bilateral lenses to decrease the possi-
bility of radiation induced cataract and resultant dose to lenses
were 0.8 Gy and 0.4 Gy right and left respectively. The patient
tolerated without any complications. Regular follow-up MRI
was done annually and revealed marked decrement of the size
of tumor successively. The tumor almost completely disap-
peared four years after GKS (Fig. 5). No complications had
developed clinically and radiologically during the follow-up
period. 
DISCUSSION
Juvenile nasopharyngeal angiofibroma is a slowly growing
tumor that is characterized by submucosal spreading, nonen-
capsulated, hypervascular, and locally destructive mass (6).
Origin of the tumor is superior posterior margin of the spheno-
palatine foramen and intracranial invasion appears in 10% to
20% of all patients with JNA and emerge more frequently in
the younger adolescent (7). Although JNA exclusively affects
adolescent male patients, the diagnosis can be made at any
age. There are several reports on giant cell angiofibroma that
have middle-age predominance and occur other sites includ-
ing orbit with histological characteristics of multinucleated
giant stromal cells (8, 9). However the histology of the au-
thors’ case showed that of typical JNA without any features
of giant cell angiofibroma.
Treatment of choice of this lesion has been surgery to the
present. The aim of surgery is complete resection with min-
imal morbidity and blood loss. Although the surgical appro-
aches are tailored by tumor stage and location of extension,
most of them need aggressive craniofacial exposure. Various
methods such as transpalatal, transfacial, transantral, trans-
maxillary, lateral rhinotomy, infratemporal, or Le Fort appro-
Fig. 1. Preoperative axial Gd-DTPA-enhanced T1-weighted magnetic resonance image (A) demonstrating homogeneously enhancing mass
in the right orbit. This mass was subtotally removed with small residual remaining in the orbital cone as postoperative computed tomogra-
phy shows (B). 
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Fig. 2. Histopathological appearance of juvenile nasopharyngeal
angiofibroma. Note typical feature of dense fibro-colllagenous tis-
sue with interspersed slit-like and gaping vascular channels (H &
E, ×45).Radiosurgery for Juvenile Nasopharyngeal Angiofibroma 775
aches have been used for the resection of tumor (6, 7). In spite
of preoperative embolization, occasional patients require intra-
and postoperative massive transfusion and are exposed to
related complications. Many papers reported on serious com-
plication of life-threatening hemorrhage during surgery (7,
10, 11). Other complications including optic neurovascular
injury, cranial nerve damage, meningitis, motor deficits, also
had been reported (12, 13). Recently, endoscopic surgery has
taken some role in limited cases. However, application of
endoscopy is allowed only in small-sized tumor without ex-
tensive involvement of the infratemporal fossa and cavernous
sinus (14). Impressive experience of using external beam radi-
ation therapy as a primary treatment modality for the man-
agement of JNA has been reported by the UCLA group (5).
Of 27 patients they reported, tumor was controlled in 23
(85%) and four patients were eventually recurred after two
to five years. However, long-term complications of radiation
therapy occurred in as many as four patients (15%) and con-
sisted of growth retardation, panhypopituitarism, temporal
lobe necrosis, cataract, and radiation keratopathy. Also others
reported secondary malignancy of the head and neck as a seri-
ous adverse effect of radiation therapy of JNA (4, 15). Both
surgery and radiation have been reported to be highly effec-
tive in the treatment and their cure rates are approximately
80% (4, 10). While the serious complications of surgical in-
tervention is immediate, the serious sequelae of radiation ther-
apy follows more protracted course, with a latency reported
to be as long as 20 yr (5). So, determining optimal therapeu-
tic management between two modalities has been a source
of controversy. Cummings (16) and Harwood et al. (17) ana-
lyzed the relative cumulative risks of developing serious com-
plications from both modalities in numerical order, and they
concluded that the two modes of treatment carried a compa-
rable cumulative risk (1 in 100).
Management of JNA by radiosurgery has rarely been tried.
Dare et al. (18) recently reported two cases of successful GKS
application in JNA as a booster treatment for residual tumor
after surgical resection. They treated residual tumor after sur-
Fig. 3. Axial (A) and sagittal (B) Gd-DTPA-enhanced T1-weighted magnetic resonance images obtained four years after the initial surgery.
Multilobulated homogeneously enhancing recurrent mass in the right orbit extending to the inferior orbital fissure and cavernous sinus is
shown. 
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Fig. 4. Axial Gd-DTPA-enhanced T1-weighted magnetic resonance
image showing dose distribution for gamma knife surgery. Total
volume is measured 6.8 cm
3. A dose of 17 Gy was delivered to the
50% isodose line of tumor margin.776 C.-K. Park, D.G. Kim, S.H. Paek, et al.
gery located in infratemporal fossa and cavernous sinus respec-
tively with delivery of 20 Gy to the tumor margin. Thirty
six months of follow-up revealed no change in size of one
patient and regression of the tumor in the other. Namely, they
documented control of postoperative residual tumor with
GKS without any complications. Intensity-modulated radi-
ation therapy, a similar form of conformal radiation therapy
as radiosurgery, has been tried for the management of exten-
sive and recurrent JNA and is reported to result in favorable
outcome (19). Except for the report of Dare et al. (18), no
report about radiosurgery on JNA could be found in English
literatures. The authors think this is the first case to document
complete regression of the pathologically proven JNA after
GKS as a primary treatment. In fact, little is known about
mechanism of radiation treatment for JNA. However, consid-
ering that JNA is composed of the mass with high vascular-
ity that is mainly hyperplastic capillaries, endothelial prolif-
eration by radiation effect may play a key role to result in vas-
cular obliteration and successive regression of the mass. 
Radiosurgery has several advantages over surgery or radia-
tion therapy. Radiosurgery is not as invasive as to surgery that
is almost free of acute complications in surgery including mas-
sive hemorrhage. Besides it is completed in a single-session
of a day treatment with no need to prolonged hospital stay.
With regard to delayed complications, radiosurgery has less
chance of risk than conventional radiation therapy theoreti-
cally because of more accurate dosimetric planning is possible
with minimal radiation delivery to the normal brain. The
safety of radiosurgery in the management of head and neck
tumors have confirmed in recent reports (20). McCombe et
al. (21) reported that typically, JNA recurs within six to 36
months. So our follow-up period of four years is thought to
be not insufficient for determining control of the tumor and
emergence of delayed complications by GKS.
Usually JNA can be exclusively diagnosed by radiological
study alone. So this report of successful treatment of JNA with
GKS may provide another indication of GKS. However, fur-
ther experiences and studies are required to confirm useful-
ness of GKS on JNA.
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